One of Bristol-Myers’s largest shareholders is opposing the company’s $74 billion deal to buy rival Celgene, becoming the latest investor to express its unhappiness with the transaction.
from WSJ.com: US Business https://ift.tt/2Vp3T2t
Subscribe to:
Post Comments (Atom)
A major curveball in retirement preparedness: divorce
Getty Images; Chelsea Jia Feng/BI Divorce can derail the best-laid retirement plans. Divorced baby boomers — especially women — often...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Stocks could crash nearly 50% and a recession might hit this year, B. Riley's Paul Dietrich said. Yuichiro Chino/Getty Images The S...
-
The benchmark S&P 500 index just logged its longest losing streak of 2023, per data from Refinitiv. Mario Tama / Getty US stocks...
No comments:
Post a Comment